How Investors Are Reacting To Rigetti Computing (RGTI) Quantum Orders And Deepening Losses

Rigetti Computing, Inc. +2.59%

Rigetti Computing, Inc.

RGTI

14.68

+2.59%

  • Rigetti Computing reported fourth-quarter 2025 sales of US$1.87 million and a net loss of US$18.21 million, while full-year sales reached US$7.09 million with a net loss of US$216.21 million.
  • Alongside these results, the company detailed new quantum system orders in India and Japan and a roadmap toward higher-qubit, higher-fidelity processors that could shape future commercial traction.
  • We’ll now examine how Rigetti’s new 108-qubit orders and deployment roadmap may influence its existing investment narrative and risk profile.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 28 best rare earth metal stocks of the very few that mine this essential strategic resource.

Rigetti Computing Investment Narrative Recap

To own Rigetti today, you have to believe that its chiplet based quantum architecture and on premises systems can eventually turn technical milestones into meaningful, higher value contracts. The latest results keep the core debate intact: the key near term catalyst is successful deployment and follow on demand for its 108 qubit systems, while the biggest risk remains heavy losses against a small revenue base, which this quarter’s US$7.09 million in annual sales and US$216.21 million net loss underline.

The most relevant announcement is Rigetti’s US$8.4 million order from India’s Centre for Development of Advanced Computing for a 108 qubit on premises system, alongside a 9 qubit Novera sale in Japan. These deals sit at the heart of the investment case, because they show customers are buying into Rigetti’s roadmap toward larger, higher fidelity processors that could support future system upgrades and usage based revenues if technical milestones are met.

Yet even with these encouraging orders, investors should be aware that Rigetti’s high cash burn and still limited revenue base mean...

Rigetti Computing's narrative projects $78.2 million revenue and $11.1 million earnings by 2029. This requires 118.6% yearly revenue growth and a $362.1 million earnings increase from $-351.0 million today.

Uncover how Rigetti Computing's forecasts yield a $38.40 fair value, a 118% upside to its current price.

Exploring Other Perspectives

RGTI 1-Year Stock Price Chart
RGTI 1-Year Stock Price Chart

Some of the most optimistic analysts once modeled revenue growing about 165% a year to roughly US$140 million by 2028, which paints a far rosier picture than the cautious view that government dependent, low margin contracts could keep revenue lumpy and losses high, so you should weigh these very different expectations against the new 108 qubit orders and what they might mean for future revisions.

Explore 42 other fair value estimates on Rigetti Computing - why the stock might be worth less than half the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Rigetti Computing research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
  • Our free Rigetti Computing research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Rigetti Computing's overall financial health at a glance.

Contemplating Other Strategies?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

  • The future of work is here. Discover the 29 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
  • Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
  • AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.